Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;34(11):2905-2909.
doi: 10.1007/s40520-022-02222-9. Epub 2022 Aug 29.

Neuropathologic validation of the Alzheimer's Questionnaire

Affiliations

Neuropathologic validation of the Alzheimer's Questionnaire

Ida Mohebpour et al. Aging Clin Exp Res. 2022 Nov.

Abstract

The Alzheimer's Questionnaire (AQ) is an informant-based screening tool with good diagnostic accuracy for Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI). The aim of this study is to validate the AQ with AD-associated neuritic plaque (NP) and neurofibrillary tangle (NFT) pathology. Data from 205 prospectively followed autopsy cases clinically classified as AD (n = 90), aMCI (n = 42), or cognitively unimpaired (CU, n = 73) were used. Semi-quantitative measures of NP and NFT pathology were correlated with the AQ, Clinical Dementia Rating Sum of Boxes (CDR-SOB), and the Mini-Mental State Exam (MMSE). The AQ correlated significantly (p < 0.001) with NP load (r = 0.37) and NFT load (r = 0.57). The MMSE and CDR-SOB showed similar correlations with NP load (r = - 0.37, r = 0.35, respectively) and NFT load (r = - 0.58, r = 0.55, respectively). The AQ correlates well with NP and NFT pathology of AD, which provides additional confidence to clinicians using the AQ to screen for AD-related cognitive impairment.

Keywords: Amyloid plaque; Dementia; Informant-based assessment; Neurofibrillary tangle; Neuropathology.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest None of the authors report any competing interests.

Figures

Fig. 1
Fig. 1
Alzheimer’s Questionnaire correlations with plaque (A) and tangle (B) load

References

    1. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurol 43:2412–2414 - PubMed
    1. Au R, Seshadri S, Knox K et al. (2012) The Framingham Brain Donation Program: neuropathology along the cognitive continuum. Curr Alzheimer Res 9:673–686 - PMC - PubMed
    1. Galvin JE, Fagan AM, Holtzman DM et al. (2010) Relationship of dementia screening tests with biomarkers of Alzheimer’s disease. Brain 133:3290–3300 - PMC - PubMed
    1. Morris GM, Holden TR, Weng H et al. (2020) Comparative performance and neuropathologic validation of the AD8 dementia screening instrument. Alzheimer Dis Assoc Disord 34:112–117 - PMC - PubMed
    1. Malek-Ahmadi M, Davis K, Belden C et al. (2012) Validation and diagnostic accuracy of the Alzheimer’s questionnaire. Age Ageing 41:396–399 - PMC - PubMed